Regulatory data is for reference only. Always verify with the official regulator before making formulation decisions. Last refreshed: 10/13/2026.
Ingredients/Acetamide
AcetamideCAS 60-35-5
EU CosIng II — prohibitedASEAN II — prohibitedChina NMPA — prohibitedUK OPSS — prohibitedBrazil ANVISA — prohibited
Is Acetamide restricted in cosmetics?
Acetamide is prohibited in EU CosIng, ASEAN, China NMPA, UK OPSS and Brazil ANVISA. Markets not named here hold no entry for it, which is not a clearance.
- CAS
- 60-35-5
- INCI
- Acetamide
- Data refreshed
- 2026-10-13
Regulatory status
| Source | Status | Annex / Details | Limit / Conditions | Last updated |
|---|---|---|---|---|
| EU CosIng | prohibited | Annex II | — | — |
| ASEAN | prohibited | Annex II | — | — |
| China NMPA | prohibited | — | — | 10/7/2026 |
| UK OPSS | prohibited | — | Source: legislation.gov.uk retained EU Regulation 1223/2009 Annex Ii | 10/5/2026 |
| Brazil ANVISA | prohibited | — | — | 10/7/2026 |
What this means
Acetamide has regulatory signals in EU CosIng, ASEAN, China NMPA, UK OPSS, Brazil ANVISA. Review the source links above for the official conditions and latest updates.
Recent regulatory changes
No recorded regulatory changes for Acetamide yet.
Common questions
- Is Acetamide restricted in EU cosmetics?
- Acetamide is prohibited in EU cosmetics according to EU CosIng Annex II.
- Is Acetamide restricted under the ASEAN Cosmetic Directive?
- Acetamide is prohibited under the ASEAN Cosmetic Directive Annex II.
- Is Acetamide restricted in China NMPA?
- Acetamide is prohibited in cosmetics under China NMPA.
- Is Acetamide restricted in UK OPSS?
- Acetamide is prohibited in cosmetics under UK OPSS.
- Is Acetamide restricted in Brazil ANVISA?
- Acetamide is prohibited in cosmetics under Brazil ANVISA.
- What is the CAS number for Acetamide?
- The CAS number for Acetamide is 60-35-5.
Check this ingredient in a formula across 11 markets
This page covers one ingredient on its own. Sign up free to check it at your actual concentration, in a full formula, with GHS hazards and per-market verdicts.